Business Segments · Goodwill

Health Sciences — Goodwill

Cognizant Health Sciences — Goodwill increased by 0.7% to $2.92B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.7%, from $2.90B to $2.92B.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2020
Last reportedQ4 2025
Rolls up toGoodwill

How to read this metric

An increase suggests recent acquisition activity or a revaluation of assets, while a decrease may indicate impairment charges due to underperformance in the segment.

Detailed definition

This metric represents the total carrying value of goodwill allocated to the Health Sciences business segment. It reflec...

Peer comparison

Peers like Accenture or Infosys report similar goodwill balances based on their specific M&A strategies within the healthcare consulting vertical.

Metric ID: ctsh_segment_health_sciences_goodwill

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$2.83B$2.82B$2.84B$2.90B$2.92B
QoQ Change-0.4%+0.7%+1.9%+0.7%
YoY Change-0.4%+0.7%+1.9%+0.7%
Range$2.82B$2.92B
CAGR+3.0%
Avg YoY Growth+0.7%
Median YoY Growth+0.7%
Current Streak3 quarters growth

Frequently Asked Questions

What is Cognizant's health sciences — goodwill?
Cognizant (CTSH) reported health sciences — goodwill of $2.92B in Q4 2025.
How has Cognizant's health sciences — goodwill changed year-over-year?
Cognizant's health sciences — goodwill increased by 0.7% year-over-year, from $2.90B to $2.92B.
What does health sciences — goodwill mean?
The total value of intangible assets like brand reputation and customer relationships acquired through past business purchases in the Health Sciences segment.